Skip to main content
. Author manuscript; available in PMC: 2009 Jun 9.
Published in final edited form as: Ann N Y Acad Sci. 2009 Feb;1155:99–111. doi: 10.1111/j.1749-6632.2009.04114.x

TABLE 1.

Kinetic Analyses of O-glucuronidation of trans-4-OH-TAM or trans-Endoxifen by UGTsa

trans-4-OH-TAM
trans-Endoxifen
UGT Vmax (pmol min−1 μg−1)b KM (μM) Vmax/KM (μl min−1 μg−1)b Vmax (pmol min−1 μg−1)b KM (μM) Vmax/KM (μl min−1 μg−1)b
1A1 3.4 ± 0.2 124 ± 16 0.028 ± 0.004 2.3 ± 0.3 333 ± 60 0.007 ± 0.0005
1A3 1.9 ± 0.3 94 ± 17.8 0.02 ± 0.001 2.9 ± 0.4 158 ± 29 0.02 ± 0.001
1A7 1.2 ± 0.2 166 ± 27 0.0074 ± 0.0002 low activityc
1A8 3.2 ± 0.2 23 ± 2.4 0.14 ± 0.02 11.6 ± 1.4 101 ± 13 0.12 ± 0.01
1A9 3.0 ± 0.1 319 ± 38 0.009 ± 0.001 low activityc
1A10 4.7 ± 0.3 96 ± 8.0 0.049 ± 0.006 5.7 ± 0.7 40 ± 3.0 0.14 ± 0.005
2B7 0.55 ± 0.18 3.7 ± 0.6 0.15 ± 0.03 3.0 ± 0.4 101 ± 17 0.03 ± 0.004
2B17 0.02 ± 0.001 41 ± 6 0.001 ± 0.0001 no detectable activityd
a

All data are the mean ± SD based on three independent experiments.

b

Data are expressed per μg UGT protein as determined by Western blot analysis.

c

Low activity describes the fact that although some glucuronidation activity was observed for a UGT enzyme against a particular TAM metabolite, the level of detection was below sensitivity for kinetic studies.

d

In addition to no detectable glucuronidation activity observed for homogenates of UGT2B15-overexpressing cells observed against trans-endoxifen, homogenates from cells overexpressing UGTs 1A6, 2B4, 2B10, 2B11, or 2B15 exhibited no detectable glucuronidating activity against trans-4-OH-TAM or trans-endoxifen.

HHS Vulnerability Disclosure